FibroGen (FGEN) Reports Q1 Loss of $0.53/Share

May 9, 2019 4:47 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.53), versus ($0.50) reported last year. Revenue for the quarter came in at $22.86 million, versus $31.93 million reported last year.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings